Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dagher, Z.
Right arrow Articles by Lorenzi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dagher, Z.
Right arrow Articles by Lorenzi, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:2404-2411, 2004
© 2004 by the American Diabetes Association, Inc.

Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy

Zeina Dagher, Yong Seek Park, Veronica Asnaghi, Todd Hoehn, Chiara Gerhardinger, and Mara Lorenzi

Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts

The polyol (sorbitol) pathway of glucose metabolism is activated in many cell types when intracellular glucose concentrations are high, and it can generate cellular stress through several mechanisms. The role of the polyol pathway in the pathogenesis of diabetic retinopathy has remained uncertain, in part because it has been examined preferentially in galactose-induced retinopathy and in part because inhibition studies may not have achieved full blockade of the pathway. Having observed that the streptozotocin-induced diabetic rat accurately models many cellular processes characteristic of human diabetic retinopathy, we tested in the diabetic rat if documented inhibition of the polyol pathway prevents a sequence of retinal vascular abnormalities also present in human diabetes. An inhibitor of aldose reductase, the rate-limiting enzyme in the pathway, prevented the early activation of complement in the wall of retinal vessels and the decreased levels of complement inhibitors in diabetic rats, as well as the later apoptosis of vascular pericytes and endothelial cells and the development of acellular capillaries. Both rat and human retinal endothelial cells showed aldose reductase immunoreactivity, and human retinas exposed to high glucose in organ culture increased the production of sorbitol by a degree similar to that observed in the rat. Excess aldose reductase activity can be a mechanism for human diabetic retinopathy.


Address correspondence and reprint requests to Mara Lorenzi, MD, Harvard Medical School, Schepens Eye Research Institute, 20 Staniford St., Boston, MA 02114. E-mail: lorenzi{at}vision.eri.harvard.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
T. Kobayashi and D. G. Puro
Loss of Insulin-Mediated Vasoprotection: Early Effect of Diabetes on Pericyte-Containing Microvessels of the Retina
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2350 - 2355.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W. Sun, P. J. Oates, J. B. Coutcher, C. Gerhardinger, and M. Lorenzi
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Diabetes, October 1, 2006; 55(10): 2757 - 2762.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. M. H. Diederen, C. A. Starnes, B. A. Berkowitz, and B. S. Winkler
Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2726 - 2731.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. S. Ola, D. A. Berkich, Y. Xu, M. T. King, T. W. Gardner, I. Simpson, and K. F. LaNoue
Analysis of glucose metabolism in diabetic rat retinas
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1057 - E1067.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Miller, D. G. Smith, M. Bhat, and R. H. Nagaraj
Glyoxalase I Is Critical for Human Retinal Capillary Pericyte Survival under Hyperglycemic Conditions
J. Biol. Chem., April 28, 2006; 281(17): 11864 - 11871.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Berrone, E. Beltramo, C. Solimine, A. U. Ape, and M. Porta
Regulation of Intracellular Glucose and Polyol Pathway by Thiamine and Benfotiamine in Vascular Cells Cultured in High Glucose
J. Biol. Chem., April 7, 2006; 281(14): 9307 - 9313.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
D.T. Graves, R. Liu, M. Alikhani, H. Al-Mashat, and P.C. Trackman
Diabetes-enhanced Inflammation and Apoptosis--Impact on Periodontal Pathology
J. Dent. Res., January 1, 2006; 85(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W. Sun, C. Gerhardinger, Z. Dagher, T. Hoehn, and M. Lorenzi
Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects
Diabetes, December 1, 2005; 54(12): 3418 - 3426.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. M. Cacicedo, S. Benjachareowong, E. Chou, N. B. Ruderman, and Y. Ido
Palmitate-Induced Apoptosis in Cultured Bovine Retinal Pericytes: Roles of NAD(P)H Oxidase, Oxidant Stress, and Ceramide
Diabetes, June 1, 2005; 54(6): 1838 - 1845.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Gerhardinger, M. B. Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu
Expression of Acute-Phase Response Proteins in Retinal Muller Cells in Diabetes
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 349 - 357.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. G. Obrosova, P. Pacher, C. Szabo, Z. Zsengeller, H. Hirooka, M. J. Stevens, and M. A. Yorek
Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications
Diabetes, January 1, 2005; 54(1): 234 - 242.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.